Sign in

NCT07525973Enrolling by invitation

The Effect of Eye Exercises in Parkinson's Disease

The Effect of Eye Exercises on Balance, Functional Mobility and Fall-Related Concern in Patients With Parkinson's Disease: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 15 Sept 2026

Brief summary (registry, in English)

Parkinson's disease is commonly associated with impaired gait, postural instability, reduced physical function, and increased concern about falling, all of which contribute substantially to disability and reduced quality of life. Exercise-based rehabilitation is increasingly recommended as a core non-pharmacological strategy for improving mobility and balance in people with Parkinson's disease. In parallel, recent clinical and neurorehabilitation research suggests that eye-movement and gaze-stabilization training may influence postural control, visuomotor integration, and movement performance in neurological disorders, including Parkinson's disease. This randomized controlled trial will evaluate whether a supervised in-center eye-exercise program can improve dynamic balance, functional mobility, gait performance, and fall-related concern in patients with Parkinson's disease.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
68 (estimated)
First submitted
6 Apr 2026
Start date
1 May 2026
Primary completion date
31 Oct 2026
Lead sponsor
Pardis Specialized Wellness Institute
NCT number
NCT07525973

What you commit to

  • Study type: Interventional
  • Planned participants: 68
  • From 1 May 2026 to the primary completion date, 31 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Change in antiparkinsonian medication during the 4 weeks before enrollment or planned medication change during the intervention period;

Other illness

  • Unstable cardiovascular, orthopedic, vestibular, or neurological condition interfering with safe participation;
  • Active infection or acute medical illness;
  • Severe uncorrected visual impairment preventing participation in eye-exercise tasks;
  • Recent myocardial infarction or stroke within the past 3 months;
  • Severe dizziness, uncontrolled vertigo, or other condition that may be worsened by eye-head coordination exercises;
  • Any other condition judged by the study physician to make participation unsafe.

Who the study is looking for

  • Adults aged 18-80 years with clinically diagnosed idiopathic Parkinson's disease;
  • Hoehn and Yahr stage 1-3;
  • Stable antiparkinsonian medication regimen for at least 4 weeks before enrollment;
  • Able to stand unaided and walk independently with or without an assistive device;
  • Adequate corrected vision to perform eye-exercise tasks;
  • Able to understand and follow simple exercise instructions;
  • Able to attend supervised in-center sessions three times per week for 8 weeks;
  • Able to provide written informed consent.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pardis specialized wellness institute
Coordinator of this site? Confirm its status
IsfahanIranUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.